If you have followed the standard treatment pathway for your condition, tried what was offered, and are still living with significant symptoms, you are in a position many people with long-term conditions know well.
For some conditions covered here, current medical understanding remains limited and treatment options are imperfect.
This article maps the fuller range of options available as alternative treatment for chronic conditions UK patients can explore, condition by condition, including where medical cannabis fits as a regulated clinical option.
For the full list of which conditions currently qualify for a medical cannabis prescription in the UK, our eligibility guide covers the criteria in detail.
Key Takeaways
- Alternative treatment does not mean unregulated or unproven. It means the next clinical step after standard first-line treatment has not given adequate relief.
- Options fall into four broad categories: physical rehabilitation, psychological approaches, NHS-based complementary therapies, and for some conditions, medical cannabis.
- The evidence base for medical cannabis varies significantly between conditions. This article reflects that honestly.
- Medical cannabis for cancer-related symptoms is supportive care alongside oncology treatment, never a replacement for it.
- A specialist consultation is always required before a cannabis-based prescription is issued.
What Alternative Treatment Actually Means Clinically
When standard first-line treatments have not provided adequate relief, the next steps typically fall into four categories.
- First, intensive physical rehabilitation: specialist physiotherapy, occupational therapy, and pain management programmes (PMPs) that combine physical and psychological support.
- Second, psychological approaches: cognitive behavioural therapy (CBT) and acceptance and commitment therapy (ACT), both recommended by the National Institute for Health and Care Excellence (NICE) for chronic primary pain.
- Third, complementary therapies offered within the National Health Service (NHS): acupuncture, relaxation therapies, and gut-directed hypnotherapy depending on the condition.
- Fourth, for a defined set of chronic conditions, a clinical assessment for a CBPM, (cannabis-based product for medicinal use) prescription through a specialist private clinic.
Which categories are relevant depends on the specific condition. The sections below break this down.
Options for Chronic Pain Alternative Treatment UK
For patients who have moved through the standard pain medication pathway and not found lasting relief, the NHS offers several further options through specialist pain services.
Pain management programmes (PMPs) are multidisciplinary programmes delivered through NHS pain clinics, combining physiotherapy, psychological support, and education. NICE recommends both CBT and ACT for chronic primary pain, not because the pain is psychological, but because these therapies help patients manage the real impact of pain that does not resolve. For specific pain sources, nerve blocks and injections may be offered by a pain specialist. Where neuropathic pain is involved, medications such as gabapentin, pregabalin, or certain antidepressants used for pain modulation may not yet have been tried.
Medical cannabis is also a realistic clinical option for patients who have tried at least two standard treatments without adequate relief. Chronic pain is one of the most common indications for private CBPM prescribing in the UK.
If you recognise your situation here, our guide to 5 signs your chronic pain may qualify for a medical cannabis prescription goes into more detail on the eligibility criteria.
Fibromyalgia Alternative Treatment UK
Fibromyalgia has no cure and limited pharmaceutical options with strong evidence. NICE recommends a patient-centred approach built around education, validated symptom management, sleep support, and staying active through supported exercise, typically in a group setting. Specific antidepressants (amitriptyline, duloxetine, and others) are recommended for their effect on pain signalling rather than as a treatment for depression. ACT and CBT are both recommended. Acupuncture is NICE-endorsed for up to five hours of treatment.
Medical cannabis has been assessed for fibromyalgia through the UK Medical Cannabis Registry. A 2026 case series published in Clinical Rheumatology, covering nearly 500 patients over 18 months, recorded improvements in fibromyalgia-specific symptoms, pain, anxiety, sleep, and quality of life.¹ Adverse events were reported by a substantial minority of patients, and the evidence remains observational rather than trial-based. This is encouraging but early, and patients should discuss the current evidence honestly with a specialist before considering it as a next step.
CRPS Alternative Treatment UK
Complex regional pain syndrome (CRPS) is a condition where current treatment options are limited. There is no licensed medication for CRPS in the UK, and the evidence base for many interventions remains incomplete. NHS treatment centres on a multidisciplinary approach: specialist physiotherapy and occupational therapy (including graded motor imagery and desensitisation techniques), neuropathic pain medications used off-label (gabapentin, pregabalin, certain antidepressants), and psychological support to help manage the emotional and functional impact of persistent pain. In selected cases, spinal cord stimulation may be considered where other integrated management has not helped.
Medical cannabis evidence for CRPS is early but notable. The first UK clinical study specifically focused on CRPS, drawn from UK Medical Cannabis Registry data on 64 patients, recorded sustained changes in pain severity and quality of life over six months, with a low reported rate of adverse events.² The cohort is small and the evidence is observational, which is important context. It is, however, the most relevant UK-specific data currently available for CRPS.
IBS Alternative Treatment
For irritable bowel syndrome (IBS) patients who have not found adequate relief from first-line dietary and medication approaches, NICE defines a structured second-line pathway. A low FODMAP diet, guided by a registered dietitian, is a recommended second-line dietary approach. Gut-directed hypnotherapy is NICE-recommended as effective for global IBS symptoms. Tricyclic antidepressants are recommended for their effect on gut-brain pain signalling, with SSRIs as a further option if tricyclics are not effective or tolerated. Psychological therapy, specifically CBT, is recommended by NICE for patients whose symptoms have not improved after 12 months of drug treatment.
The evidence base for medical cannabis in IBS specifically is more limited than for the other conditions. For a fuller look at what the current research shows about medical cannabis and IBS, see our dedicated guide, which covers the current UK registry data honestly.³
Options for People Affected by Cancer
This must be clear from the outset: no alternative treatment replaces oncology treatment for cancer. Every option discussed here is supportive care, used alongside active oncology treatment, in coordination with your oncology team, not instead of it
Within that boundary, people affected by cancer often have access to NHS-based complementary therapies through cancer support services and hospice teams. These include relaxation therapies, acupuncture, and counselling. Cancer Research UK provides a summary of where these therapies are available through NHS and hospice settings.⁴
Medical cannabis may be considered as part of supportive care for cancer-related symptoms, specifically pain, nausea, appetite loss, and sleep disruption, alongside and not in place of active oncology treatment. This is not a treatment for cancer itself. Any consideration of a CBPM prescription must involve your oncology team.
Our guide on 5 ways medical cannabis may support quality of life during cancer treatment explores this supportive role in more depth.
Getting a Specialist Opinion at LeafEase
LeafEase is a Care Quality Commission (CQC)-registered private medical cannabis clinic. All prescriptions are issued by GMC-registered specialist clinicians following a thorough review of your diagnosis, treatment history, and individual clinical circumstances. Medical cannabis has been prescribed only five times on the NHS since it became legal in 2018; for most patients with the conditions covered in this article, a private specialist clinic is the only realistic route. If a prescription is not clinically appropriate, patients are told clearly why, and the consultation fee is refunded in full. To understand how a LeafEase specialist consultation works in practice, our how-it-works page covers each stage.
When you are ready to find out whether you may be eligible, you can check your eligibility at LeafEase in a few minutes.
Frequently Asked Questions
What is classed as an alternative treatment for chronic conditions?
In a clinical context, alternative treatment refers to options pursued when standard first-line treatment has not provided adequate relief , not unproven or unregulated therapies. For chronic conditions, this typically includes pain management programmes, psychological therapies such as CBT and ACT, NICE-recommended complementary therapies, and in some cases, a specialist assessment for medical cannabis.
Is there an alternative treatment for CRPS in the UK?
There is no licensed medication for CRPS in the UK. NHS treatment focuses on a multidisciplinary approach combining specialist physiotherapy, off-label neuropathic pain medications, and psychological support. Medical cannabis evidence for CRPS is early but exists: a 2025 UK registry study covering 64 patients recorded sustained changes in pain severity and quality of life over six months.
What are the alternative treatment options for fibromyalgia?
NICE recommends education, supported exercise, ACT or CBT, specific antidepressants used for pain modulation, and acupuncture. For patients who have not found adequate relief from these approaches, a specialist assessment for medical cannabis may be relevant. UK registry data covering nearly 500 patients over 18 months has recorded improvements in pain, sleep, and quality of life. A substantial minority reported adverse events.
Are there alternative treatments for cancer?
No alternative treatment replaces oncology treatment for cancer. Supportive options available alongside active treatment include NHS-based complementary therapies such as acupuncture, relaxation, and counselling, often available through cancer support services and hospice teams. Medical cannabis may be considered for symptom management (pain, nausea, appetite, sleep) as a complement to oncology care, in coordination with your oncology team.
What can help with IBS when standard treatment hasn’t worked?
NICE recommends a low FODMAP diet (a specialist eating plan that limits certain fermentable carbohydrates known to trigger gut symptoms) with dietitian support, gut-directed hypnotherapy, and second-line medications including tricyclic antidepressants. CBT is recommended for patients whose symptoms persist after 12 months of drug treatment. The evidence for medical cannabis in IBS specifically is more limited than for other chronic conditions and should be discussed with a specialist.
Does medical cannabis work for chronic pain when other treatments have failed?
UK registry data consistently records improvements in pain intensity, sleep, and quality of life in chronic pain patients prescribed CBMPs. It is not effective for everyone and individual responses vary. Eligibility requires a confirmed diagnosis and evidence that at least two prior treatments have not provided adequate relief. A specialist assessment is the only way to determine whether it may be appropriate for a specific patient.
References
1] Varadpande, M., Erridge, S., Aggarwal, A., et al. (2025) UK Medical Cannabis Registry: a case series analysing clinical outcomes of medicinal cannabis therapy for fibromyalgia. Clinical Rheumatology. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12923461/ Accessed: August 2026].
2] Evans, L., Erridge, S., Varadpande, M., et al. (2025) UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Complex Regional Pain Syndrome. Brain and Behavior, 15(9), e70823. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC12405601/ Accessed: August 2026].
3] Erridge, S., Sodergren, M.H., et al. (2023) The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. European Journal of Gastroenterology and Hepatology, 35(2), pp.157–164. Available at: https://doi.org/10.1097/MEG.0000000000002486 Accessed: August 2026].
4] Cancer Research UK (2025) Where you can go to have complementary therapies. Available at: https://www.cancerresearchuk.org/about-cancer/treatment/complementary-alternative-therapies/about/where-you-can-go Accessed: August 2026].
5] NICE (2021) Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain. NICE Guideline NG193. Available at: https://www.nice.org.uk/guidance/ng193 Accessed: August 2026].
6] NICE (2017) Irritable bowel syndrome in adults: diagnosis and management. NICE Clinical Guideline CG61. Available at: https://www.nice.org.uk/guidance/cg61 Accessed: August 2026].
7] NHS (2022) Complex regional pain syndrome. Available at: https://www.nhs.uk/conditions/complex-regional-pain-syndrome/ Accessed: August 2026].
